Refractory Lung Small Cell Carcinoma

general

Small cell lung carcinoma that does not respond to treatment.

19

Centers

23

Active Trials

$2.6B

Cancer Funding

Specific Cancer Types(1)

Top Centers for Refractory Lung Small Cell Carcinoma(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
55.0
2
NCI Comprehensive
Active Research Program
55.0
3
NCI Comprehensive
Active Research Program
55.0
4
NCI Comprehensive
Active Research Program
55.0
5
NCI Comprehensive
Active Research Program
55.0
6
NCI Comprehensive
Active Research Program
55.0
7
NCI Comprehensive
Active Research Program
55.0
8
NCI Clinical
Active Research Program
55.0
9
Active Research Program
55.0
10
NCI Comprehensive
Active Research Program
55.0
11
12
13
14
NCI Comprehensive
15
16
NCI Comprehensive
17
NCI Comprehensive
18
19

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →